User Tools

Site Tools

Trace: • drug_page
basics:start

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
basics:start [2026/02/12 21:09] – [Histamine Pathway] andrew2393cnsbasics:start [2026/02/12 21:11] (current) – [High-Yield Framework] andrew2393cns
Line 18: Line 18:
 ---- ----
  
 +===== High-Yield Framework =====
 +
 +  * Innate immunity initiates inflammation.
 +  * Adaptive immunity provides specificity and memory.
 +  * Th1/Th17 drive autoimmune inflammation.
 +  * Th2 drives allergic disease.
 +  * COX pathway → prostaglandins.
 +  * 5-LOX pathway → leukotrienes.
 +  * NSAIDs block COX.
 +  * COX-2 inhibitors selectively block inflammatory COX-2.
 +  * Leukotriene modifiers block bronchoconstrictive leukotrienes.
 +  * Corticosteroids suppress upstream inflammatory transcription.
 +  * Biologics target specific cytokines.
 +
 +----
 ===== I. Core Immune Physiology ===== ===== I. Core Immune Physiology =====
  
Line 129: Line 144:
 Drug modulation: Drug modulation:
  
-[[allergy:drug_classes:first_generation_h1]] +  * [[allergy:drug_classes:first_generation_h1|First Generation Antihistamines]] 
-[[allergy:drug_classes:second_generation_h1|Second Generation Antihistamines]]+  * [[allergy:drug_classes:second_generation_h1|Second Generation Antihistamines]]
   * [[endocrine:drug_classes:corticosteroids|Corticosteroids]]   * [[endocrine:drug_classes:corticosteroids|Corticosteroids]]
   * Epinephrine   * Epinephrine
Line 145: Line 160:
 Drug Modulation Drug Modulation
  
-  * [[immunology:complement_inhibitors|Complement Inhibitors]]+  * [[immunology:drug_classes:complement_inhibitors|Complement Inhibitors]]
  
 ---- ----
Line 257: Line 272:
   * [[immunology:biologics:abatacept|Abatacept]]   * [[immunology:biologics:abatacept|Abatacept]]
  
-===== High-Yield Framework ===== 
- 
-  * Innate immunity initiates inflammation. 
-  * Adaptive immunity provides specificity and memory. 
-  * Th1/Th17 drive autoimmune inflammation. 
-  * Th2 drives allergic disease. 
-  * COX pathway → prostaglandins. 
-  * 5-LOX pathway → leukotrienes. 
-  * NSAIDs block COX. 
-  * COX-2 inhibitors selectively block inflammatory COX-2. 
-  * Leukotriene modifiers block bronchoconstrictive leukotrienes. 
-  * Corticosteroids suppress upstream inflammatory transcription. 
-  * Biologics target specific cytokines. 
basics/start.1770930575.txt.gz · Last modified: by andrew2393cns